Safety Alerts and Recalls on Heart Devices : ICDs & Pacemakers. Presevter: Emanuel 09-11-2001 CIS 763 PRESENTATION BC/CUNY.

Slides:



Advertisements
Similar presentations
Appendix E Pacemakers Gail Walraven, Basic Arrhythmias, Seventh Edition ©2011 by Pearson Education, Inc., Upper Saddle River, NJ.
Advertisements

Remote follow up: Where are we now? Has it improved services to our patients? LYDIA BRADLEY CRM DEVICES LEAD PHYSIOLOGIST.
By Sam Annor (EE5811-Biomedical Instrumentation-Fall 2007).
Patient Contact Careers Naomi Cox Product Specialist and Territory Manager- St Jude Medical Australia.
 Used three-lead ECG data from 26 patients admitted to hospitals following non- ST-elevation acute coronary syndrome.  Applied three different nonlinear.
PREAPRED BY; Moneer al-aliowh SUPERVISED BY; D, yshmen al-fholy
Department of Anesthesia and Perioperative Care advancing health worldwide TM Combined ICD/Pacing Devices What options are available? What’s new in the.
Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)
Automated External Defibrillation
FDA Workshop External Defibrillator Improvement Initiative December 15-16, 2010 MDR Reporting Factors Over the Past 5 Years Derek Smith Senior Vice President.
Impact of Anticoagulant and Anti-platelet Therapy on ICD Implant-Related Bleeding and Thromboembolic Events in Patients Enrolled in the NCDR ® ICD Registry.
William H. Maisel, MD, MPH Director, Medical Device Safety Institute Beth Israel Deaconess Medical Center Statement to the FDA Risk Communication Advisory.
University of Florida, Jacksonville, FL
Jennifer Cohen, MD, Heather Costa, PhD, Robert Russo, MD, PhD, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, CA The MagnaSafe Registry:
Pacemakers and Implantable Cardioverter-Defibrillators
Medicine and Computers Tom Wesley. NEOUCOP Northeastern Ohio Universities College of Pharmacy Northeastern Ohio Universities College of Pharmacy Given.
Pacemakers and Implantable Defibrillators
Implantable Cardioverter Defibrillator Rebecca Boduch Biomedical Engineering University of Rhode Island.
Digital Ocular Recording Device Robert Arriaga Donald Githens Marc Martin.
External Defibrillators: Recalls, Inspections, and the Quality System Regulation Melissa Torres Office of Compliance December 15, 2010.
Arrhythmias Medical Student Teaching Tuesday 24 th January 2012 Dr Karen Jones, SpR Emergency Medicine.
Zhihao Jiang, Rahul Mangharam PRECISE Center University of Pennsylvania.
Pacemakers and Implanted Defibrillators Mike Harlan.
Adverse Event Reports on Automatic External Defibrillators from Oscar H Tovar MD and Beverly Gallauresi RN, MPH Food and Drug Administration.
FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.
Internship Experience At Medtronic Inc.
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
FDA Regulatory review in Minutes: What Product Development Executives Need-to-Know. Specifically, frequent causes of recalls and related areas that investigators.
The Latest Device Therapy in W. Herts Dr Philip Moore.
St. Jude Medical Edmundo Lozano June 21, Stock Information Ticker: STJ Price (June 18, 2010): $ week range: $ $42.87.
AEDs Do Not Improve Survival from In-Hospital Arrest Summary and Comment by Daniel J. Pallin, MD, MPH Dr. Pallin is an attending physician in the Department.
Security and Privacy for Implantable Medical Devices Presented by : Dilip Simha.C.R.
Wireless Cardiac Device Monitoring Presented by: Ashley D. Solomon, RN Nursing 457: Nursing Informatics Fall 2009.
ELECTRODES FOR STIMULATION. Cardiac Pacemakers and Defibrillators  The heart is a natural example of a critical Bioelectromagnetic system.  An electrocardiogram.
Cleveland Clinic Science Internship Program for Nursing Patient Perception: Quality of Life Before and After Pacemaker Implantation Dedra Teel, Cathy Cerny.
IHE ITI – Dec 2006What IHE Delivers 1 Nicholas Steblay Implantable Device Cardiac Observations (IDCO) Profile.
Rules for Supporting Part 803 and Part 806 Decision Making Page 1 Establishing Rules for: Medical Device Reports (803) & Correction and Removal Reports.
BME 181 March 4, 2013 Presented by: Corey Gomes. J.A. McWilliams Late 1800’s Electrical impulses John Hopps Radio frequencies Mechanical and electrical.
IMPLANTABLE DEFIBRILLATOR By: Victor J. Gabbidon.
IHE Workshop – June 2007What IHE Delivers 1 Nicholas Steblay Boston Scientific Implantable Device Cardiac Observations (IDCO) Profile.
Pacing the Heart Ayo Ositelu ECE 5030 Final Presentation Tuesday, 15 December 1:00pm.
FDA job description  Regulates about 25% of all consumer purchases  Mission summary: protect and advance public health  Products: food, cosmetics, drugs,
MarketsandMarkets Presents Cardiac Monitoring Market worth $23.3 Billion – 2017
V Cardiac Equipment Market Size, Share, Global Trends, Company Profile, Demand, Insights, Analysis, Research, Report, Opportunities, Forecast,
1 Overview  Problem Review  Solutions Review  Results  Assessment and Feedback  Ethics: “Moral Blindness and the Guidant Recall”  Closure Writing.
Methodological Issues in Implantable Medical Device(IMDs) Studies Abdallah ABOUIHIA Senior Statistician, Medtronic.
Shock Reduction History James Coles, PhD Medtronic, Inc.
Date of download: 6/1/2016 From: Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure Ann Intern Med. 2004;141(5):
Date of download: 6/8/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Pacemaker and ICD Generator Malfunctions: Analysis.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
METHODS The EASYTRAK 2 lead was studied along with the CONTAK  RENEWAL  2/4/4HE device in the Device Evaluation of the CONTAK RENEWAL 2/4/4HE with EASYTRAK.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Safety and Efficacy of the Totally Subcutaneous Implantable.
Karen M. Sandler General Counsel July 23, 2010 OSCON Free Software on Medical Devices: Unchain My Heart!

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;
U.S. FDA Center for Devices and Radiological Health Update
Published on – 1 August, 2016 | Number of pages : 150
Video Capsule Endoscopy in Patients with Implantable Cardiac Devices: Safety, Interference and Beyond Rabih Tabet MD, Najib Nassani MD, MSc, Boutros Karam.
Deactivating the shocking component of an Implantable Cardioverter Defibrillator (ICD) (When no longer appropriate)
Annual Outcomes With Transcatheter Valve Therapy
Laurie Racenet, FNP, MSN, CCDS, CEPS, FHRS
Global Active Implantable Medical Devices Market to Witness 8% CAGR during 2017 – 2023.
Systematic Reviews and Medical Policy Determinations
Annual Outcomes With Transcatheter Valve Therapy
Volume 6, Issue 10, Pages (October 2009)
Volume 6, Issue 12, Pages (December 2009)
Tobey Clark, Director*, Burlington USA
Volume 7, Issue 11, Pages (November 2010)
Automated External Defibrillation
Presentation transcript:

Safety Alerts and Recalls on Heart Devices : ICDs & Pacemakers. Presevter: Emanuel CIS 763 PRESENTATION BC/CUNY

Objective Objective To present an overview on the topic of hardware and software errors in the safety alerts and recalls of pacemakers and ICDs.

ICDs & PACEMAKERS – WHAT ARE THEY? An ICD (implantable cardioverter defibrillator) looks much like a pacemaker. It is "implanted", or put in your body surgically. Whereas pacemakers can speed up a slow heart rate, ICD therapy generally slows down a fast heart rate. It is like a small computer that runs on a battery. Or, ICDs are high-tech devices that contain sophisticated detection algorithms and tiered therapy options. The ICD system consists of an ICD, one or two leads, and a programmer The ICD system consists of an ICD, one or two leads, and a programmer. A typical ICD is often four to five ounces in weight, less than two inches wide and a half-inch thin. The device is roughly the size of four to five silver dollars stacked on top of one another.

Biotronik St. Jude Medical Guidant Medtronic ICD   PACEMAKER

The term "pacemaker" is used for a small, battery- operated device that helps the heart beat in a regular rhythm. Some are permanent (internal) and some are temporary (external). It can replace a defective natural pacemaker or blocked pathway.

Programmers A programmer enables a physician to evaluate an ICD's performance and change its settings non- invasively. For example: St. Jude Medical CRMD's proprietary software enhances ICD function, offering comprehensive diagnostic capabilities. It uses a Pentium-processor-based programmer. PR-3500 Programmer

WHY I MIGHT NEED AN ICD? Normally, your heart has a natural pacemaker that helps your heart beat steadily. You may need an ICD if you have had, or are at high risk of having, certain heart rhythm problems. SOURCE: ARE ICDs USED WIDELY? Japan Airlines Purchases 130 Automated External Defibrillators From Cardiac ScienceAirline to Outfit All International Flights With AEDs SOURCE: PRNewswire About 900,000 people in the USA, including Vice President Cheney, wear pacemakers or ICDs 1

RECALLS AND FIELD CORRECTIONS: DEVICES -- CLASS II ________ PRODUCT Medtronic Implantable Cardioverter Defibrillators: a) Medtronic Micro Jewel II Implantable Cardioverter Defibrillator, Model 7223CX; b) GEM DR Model 7271 Implantable Cardioverter Defibrillator. Recall #Z-261/ CODE All serial numbers of the Model 7223CX; Serial Numbers PIM200002R through PIM302777R and PIM400352R, PIM400968R, and PIM400969R of the Model 7271 Defibrillators. MANUFACTURER Medtronic Med Rel, Inc., Humaco, Puerto Rico; Medtronic, B.V., Kerkrade, European Service and Technology Center, The Netherlands; Medtronic, Switzerland Manufacturing Operations, Tolochenaz, Switzerland. RECALLED BY Medtronic, Inc., Minneapolis, Minnesota, by letter dated August 1999 for the Model 7223CX Defibrillators and by letter dated December 1999 for the Model 7271 Defibrillators. Devices having capacitor charge times above a certain level are being reprogrammed. Firm-initiated field correction ongoing. DISTRIBUTION Nationwide and international. QUANTITY Approximately 28,000 units were distributed. REASON Some of the devices have extended charge times for the high- voltage capacitors used to store the charge for cardioversion and defibrillation therapies. RECALL

ANY STUDIES………YES ! Krannert Institute of Cardiology Case.. A 70-year-old patient experience an acute dizziness, and was found to have a loss of ventricular output due to an internal software problem. This was corrected by software programming via the programmer. Comment Although this article was written to exemplify the potential ability of correcting new generation ICD software problems non- invasively, it does not minimize the importance of a life-threatening software failure. CASE 1:

Design and Setting Analysis of weekly FDA Enforcement Reports issued between January 1990 and December Recalls and safety alerts involving lead malfunctions were not included. Main Outcome Measures Number of pacemakers and ICD generators in the United States subject to FDA recall or safety alert in Brigham and Women Hospital’s Study… Context Unanticipated pacemaker and ICD generator malfunctions sometimes warrant recall by the US Food and Drug Administration (FDA). Objectives To determine pacemaker and ICD generator advisory rates in the United States, to identify trends in these rates, and to examine their clinical and financial implications. CASE 2:

Results of Study 1.During the study period, 52 advisories, involving pacemakers and ICDs were issued. 2.Hardware malfunctions and computer errors accounted for 95% of device recalls 3.Implantable cardioverter-defibrillators were recalled more frequently than pacemakers. 4.Between 1995 and 2000, the annual advisory rate increased for both pacemakers 5.An estimated 1.3 million device checks and analyses and device replacements resulted from the advisories and cost approximately $870 million.

COMMENTS & RECOMMENDATIONS Nearly 20% of pacemaker wearers could not live without one Hardware problems and computer programming errors were the most common basis for recalling both pacemakers and implantable defibrillators. "Some (flaws) are potentially life-threatening and require device replacement," says William H. Maisel, MD, MPH of BWH of Harvard Medial School. Kim Eagle of the University of Michigan Medical Center said in an accompanying editorial that routine recalls are not unexpected "in a free-market society that highly rewards profit and attends to safety primarily through its violation." Eagle called for: A longer testing period for pacemakers. A longer testing period for pacemakers. Closer regulation of the testing process. Closer regulation of the testing process. The creation of a better "device tracking system" involving "more parties than industry alone." The creation of a better "device tracking system" involving "more parties than industry alone." By studying devices that fail, researchers might learn how to improve their reliability. Source: USATODAY Healthscience News August 14, 2001

CONCLUSION Pacemaker and ICD recalls and safety alerts occur frequently, affect many patients, and appear to be increasing in number and rate. Improve the methodology of reporting these flaws. Remedy for these failures should be improved hardware/software engineering methods.

SOURCES… Coppess MA, Miller JM, el. Software error resulting in malfunction of an implantable Cardioverterdefibrillator. J Cardiovasc Electrophysiol 1999 Jun;10(6):871-3 Maisel WH, el. Recalls and safety alerts involving pacemakers and implantablecardioverter- defibrillator generators. JAMA Aug 15;286(7):843-4 Maisel WH, el. Recalls and safety alerts involving pacemakers and implantablecardioverter- defibrillator generators. JAMA Aug 15;286(7):843-4 Kaczmarek RG, Beaulieu MD, Kessler LG. Medical device tracking: results of a case study of the implantable cardioverterdefibrillator. Am J Cardiol 2000 Mar 1;85(5): Eagle KA. Safety alerts involving device therapy for arrhythmias. JAMA Aug 15;286(7):843-4.

The End !